Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease-related and psychosocial factors associated with difficult-to-manage and treatment-refractory axial spondyloarthritis: insights from the Greek AxSpA Registry.

Rheumatology international·2026
Same author

Myocarditis as the first sign of SLE: a case report and review of the literature.

Rheumatology international·2026
Same author

Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort study.

Autoimmunity reviews·2026
Same author

Late-onset psoriatic arthritis: data from a nationwide cross-sectional study.

Therapeutic advances in musculoskeletal disease·2025
Same author

A cadaveric study of incidence and surgical anatomy of Meckel's diverticulum: an obituary to prof. Georgios Apostolakis (1890-1964).

Acta chirurgica Belgica·2025
Same author

Intravenous Immunoglobulin in Acute Exacerbations of Fibrotic Interstitial Lung Diseases: A Retrospective, Real-World Study.

Medicina (Kaunas, Lithuania)·2025

Related Experiment Video

Updated: May 21, 2026

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR

Dimitrios Daoussis1, Athanassios C Tsamandas, Stamatis-Nick C Liossis

  • 1Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Patras, Rion, 26504, Greece. jimdaoussis@hotmail.com

Arthritis Research & Therapy
|June 16, 2012
PubMed
Summary

Rituximab (RTX) treatment may reduce skin fibrosis in systemic sclerosis (SSc) by decreasing platelet-derived growth factor receptor (PDGFR) activation. This suggests RTX has a disease-modifying role in SSc.

More Related Videos

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
08:01

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Published on: November 4, 2016

Related Experiment Videos

Last Updated: May 21, 2026

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
08:01

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Published on: November 4, 2016

Area of Science:

  • Immunology
  • Dermatology
  • Rheumatology

Background:

  • Systemic sclerosis (SSc) is a fibrotic disease.
  • Rituximab (RTX) shows promise in treating SSc.
  • The mechanism of RTX's effect on fibrosis is being investigated.

Purpose of the Study:

  • To explore if RTX reduces fibrosis in SSc by affecting the platelet-derived growth factor receptor (PDGFR) pathway.
  • To assess changes in PDGFR expression and activation after RTX treatment in SSc patients.

Main Methods:

  • Skin biopsies from SSc patients before and after RTX treatment were analyzed.
  • Immunohistochemistry was used to measure PDGFR, phosphorylated PDGFR, and platelet-derived growth factor.
  • Expression levels were compared between treated patients, control SSc patients, and healthy subjects.

Main Results:

  • PDGFRα and PDGFRβ expression strongly correlated with fibrosis in SSc skin.
  • RTX treatment significantly decreased PDGFRα and PDGFRβ expression in the papillary dermis.
  • Phosphorylated PDGFRα and PDGFRβ levels also significantly decreased after RTX administration.

Conclusions:

  • RTX may improve skin fibrosis in SSc by reducing PDGFR pathway activation.
  • These findings support a disease-modifying potential for RTX in SSc.
  • Larger studies are needed to confirm RTX efficacy in SSc.